PW03-014B - Gene-expression profiling study in FMF families by unknown
MEETING ABSTRACT Open Access
PW03-014B - Gene-expression profiling
study in FMF families
B Aygun1, M Carrabba2,3*, M Fabbri1,4, L Gribaldo1, M Zarantonello3, G Fabio2,3
From 7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Lausanne, Switerland. 22-26 May 2013
Introduction
The inflammasome complex and the inflammatory path-
way have been implicated in the pathogenesis of familial
Mediterranean fever (FMF), and recently ASC (apopto-
sis-associated speck-like protein containing a CARD)
mRNA expression was found to be up-regulated in
patients carrying MEFV mutations independent of the
mutation type. Gene-expression profiling has the capa-
city to reveal transcriptome profiles to discriminate dis-
ease “phenotypes” to understand a given disease and
bring to light new diagnostic and predictive biomarkers.
Objectives
This pilot study focuses on comparative gene expression
profiling in FMF patients with different phenotypes
while bearing the same mutations in the search of signa-
ture patterns.
Methods
Members of two different families representing different
mutation sets were subjects of the study. mRNA expres-
sion in carriers of the same MEFV mutation that exhibit
different phenotypes was comparatively analyzed. Total
mRNA was extracted from peripheral blood. Microarray
analysis was run on Human 8X60 K Microarray slides
and analyzed for whole genome expression levels using
an Agilent Scanner.
Results
A within-group analysis of candidate genes for each
family was carried out by comparison of gene expression
levels in all family members with clinical FMF versus
the member without FMF. Although variation in mRNA
levels of inflammation related genes such as NLRP3,
NLRP1, PYCARD, MEFV, NLRC4, CASP1, PSTPIP1
was observed it was not possible to identify a signature
pattern of expression either within-family analysis or
comparison between investigated families.
Subsequently, total gene expression was analysed using
as threshold a log fold change of 1 or -1 and pathway
enrichment was performed using DAVID (the Database
for Annotation, Visualization and Integrated Discovery).
In the first family composed of the grandmother, her
son and her nephew, all heterozygous for M694V, we
compared the two subjects with clinical diagnosis of
FMF (son and nephew), in complete remission under
colchicine, to the healthy carrier (grandmother).We
obtained a list of 73 genes regulated in the same direc-
tion. A significant enrichment in the pathways of regula-
tion of amyloid precursor protein biosynthetic process,
regulation of T-helper 2 type immune response, regula-
tion of glycoprotein biosynthetic process was found.
In the second family, composed of the father, his son
and his daughter all carrying the complex allele E148Q/
R761H, we compared the two subjects with clinical
diagnosis of FMF (son and daughter), in complete
remission under colchicine, to the healthy carrier
(father). We obtained a list of 48 genes regulated in the
same direction. A significant enrichment was found in
the pathways of negative regulation of apoptosis, inflam-
matory/defense response, cellular ion homeostasis, regu-
lation of activated T cell proliferation.
Conclusion
This pilot study investigated pathways involved in geno-
type/phenotype correlation in two families manifesting
FMF via mRNA gene-expression profiling. Different
mutations seem to exert their effects involving different
pathways. For any conclusive generalization higher num-
ber of patients and representative families are needed to
be investigated.
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